In France, the Office of Public Health recommended citizens under the age of 30 not vaccinated with Moderna’s Spikevax for vaccination against coronavirus. Instead, the French were given a recommendation use the Pfizer vaccine.
Writes about it Reuters… This decision is associated with a possible high risk of side effects. In particular, we are talking about heart disease.
The country’s Supreme Health Council (HAS), which serves as an advisor to the French health sector, cited “very rare” risks associated with myocarditis. About them, as specified, said in the results of a study published on November 8.
The HAS concluded that with the Pfizer vaccine, the potential risk of such diseases among people under thirty is about five times less. Such a recommendation, as specified, will remain valid until further scientific evidence is available on this matter.
–
Note that earlier the European Union regulatory body EMA approved the drug Moderna for booster vaccination of all age groups over 18 years old, at least six months after the second dose.
Recall: in October 2021, the Scandinavian countries refused the Moderna vaccine against COVID-19 for young people due to the possible occurrence of myocarditis and pericarditis, as well as inflammation of the heart or its inner lining. For this reason, Denmark, Sweden and Norway will not use it for people born in 1991 and later. Potential side effects were highlighted in an unpublished study by the Swedish Health Agency.
As reported OBOZREVATEL, New Research Shows Moderna’s Vaccine (mRNA-1273) May Be Effective in the prevention of infection with the Delta strain by 73.1%. Also, the drug has shown a high result in the prevention of severe course and death.
–
